French recommendations for the management of systemic sclerosis
Open Access
- 26 July 2021
- journal article
- research article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 16 (S2) , 1-61
Abstract
Systemic sclerosis (SSc) is a generalized disease of the connective tissue, arterioles, and microvessels, characterized by the appearance of fibrosis and vascular obliteration. There are two main phenotypical forms of SSc: a diffuse cutaneous form that extends towards the proximal region of the limbs and/or torso, and a limited cutaneous form where the cutaneous sclerosis only affects the extremities of the limbs (without passing beyond the elbows and knees). There also exists in less than 10% of cases forms that never involve the skin. This is called SSc sine scleroderma. The prognosis depends essentially on the occurrence of visceral damage and more particularly interstitial lung disease (which is sometimes severe), pulmonary arterial hypertension, or primary cardiac damage, which represent the three commonest causes of mortality in SSc. Another type of involvement with poor prognosis, scleroderma renal crisis, is rare (less than 5% of cases). Cutaneous extension is also an important parameter, with the diffuse cutaneous forms having less favorable prognosis.Keywords
This publication has 96 references indexed in Scilit:
- Nutritional Support in the Severely Compromised Motility Patient: When and How?Gastroenterology Clinics of North America, 2011
- Systemic sclerosis and the heartCurrent Opinion in Rheumatology, 2011
- Effect of orofacial exercises on oral aperture in adults with systemic sclerosisDisability and Rehabilitation, 2011
- Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patientsAnnals of the Rheumatic Diseases, 2009
- Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle studyRheumatology, 2009
- Efficacy of connective tissue massage and Mc Mennell joint manipulation in the rehabilitative treatment of the hands in systemic sclerosisClinical Rheumatology, 2009
- High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacyArthritis Research & Therapy, 2009
- Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2007
- The Diagnosis and Treatment of??Raynaud???s PhenomenonDrugs, 2007
- Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ)Clinical Rheumatology, 2004